Observational Study of Biphasic Insulin Aspart 30 Alone or in Combination With Oral Hypoglycaemic Agents in Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Novo Nordisk A/S
Related studies linked through entity extraction aliases.
Comparison of the Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 and Insulin Aspart in Subjects With Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
- Status
- COMPLETED
- Phase
- N/A
Bioequivalence of Two Insulin Aspart Formulations (100 U/mL Versus 200 U/mL)
- Status
- COMPLETED
- Phase
- PHASE1
Genetic Testing of Noonan Subjects Previously Treated With Norditropin®. An Extension to Trial GHNOO-1658
- Status
- COMPLETED
- Phase
- PHASE3
Somatropin Effect on Linear Growth and Final Height in Subjects With Noonan Syndrome
- Status
- COMPLETED
- Phase
- PHASE3
Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Japanese Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Glycaemic Control of Biphasic Insulin Aspart 70 and 30 in Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of Single Dose and Steady State Pharmacodynamics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
Comparison of Two Formulations of Biphasic Insulin Aspart 70
- Status
- COMPLETED
- Phase
- PHASE1
Comparison of Biphasic Insulin Aspart (30, 50 and 70) and Insulin Aspart in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of Two Biphasic Insulin Aspart Treatments in Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and Metformin
- Status
- COMPLETED
- Phase
- PHASE4